Neuberger Berman Group »

Legend Biotech 2 Adr Rep Ord shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Legend Biotech 2 Adr Rep Ord (LEGN) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Legend Biotech 2 Adr Rep Ord

Tip: Access up to 7 years of quarterly data

All positions including Legend Biotech 2 Adr Rep Ord held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Legend Biotech 2 Adr Rep Ord by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $376k 6.2k 60.17

More positions owned by Neuberger Berman Group

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Jpmorgan Chase & Co Common (JPM)
Nvidia Corp Common (NVDA)
Alphabet Inc-cl C Common (GOOG)
Alphabet Inc Class A A Common (GOOGL)
Berkshire Hathaway Inc Class B Common (BRK.B)
T Mobile Us Common (TMUS)
Johnson & Johnson Common (JNJ)
Procter & Gamble Co/the Common (PG)
Unitedhealth Group Common (UNH)
Nextera Energy Common (NEE)
Eli Lilly & Co Common (LLY)
Progressive Corp Common (PGR)

View all positions for Neuberger Berman Group

Top funds holding Legend Biotech 2 Adr Rep Ord

T. Rowe Price Associates
RA Capital Management
Hillhouse Capital Advisors
Wellington Management Company
Massachusetts Financial Services
Paradigm Biocapital Advisors
Henderson Group
Westfield Capital Management Company
Holocene Advisors
Federated Investors
Alliancebernstein
TimesSquare Capital Management
Arrowpoint Asset Management
Matthews International Capital Management
Avidity Partners Management

View all funds holding Legend Biotech 2 Adr Rep Ord